Vimarsana
Biggest News Aggregation in the World

Booster Timeline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Booster Timeline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Booster Timeline Today - Breaking & Trending Today

MSNBC Deadline White House January 5, 2022 22:19:00 - Vimarsana News

MSNBC Deadline White House January 5, 2022 22:19:00

Another group could get access to the booster shots this week. the cdc's advisory panel endorsed pfizer's third dose for 12 to 15-year-olds, the first booster shot for people younger than 16. the fda gave it their okay on monday and it now goes to the cdc director for final approval. it also comes one day after the cdc green lit pfizer's booster for younger immunocompromised kids and shortened the booster timeline. recommending a third shot after the first two five months instead of six, after the second shot was administered. when we come back, how dangerously close we came to a full blown co...

CNN Don Lemon Tonight December 16, 2021 07:38:00 - Vimarsana News

CNN Don Lemon Tonight December 16, 2021 07:38:00

Do you think the booster timeline should be shortened? >> i would say at this point other countries are shortening the timeline to 4 or 4 1/2 months. it certainly would make sense given the accumulating data around omicron that shortening the timeline in the states as well would make sense. there's also questions about that 12 to 16-year-old age group who have not been approved for boosters. many of those kids did get vaccinated in april and may when the vaccines first became available. we're waiting for more data on them on safety and efficacy. but i suspect that boosters for them as well are...

CNN CNN Newsroom With Ana Cabrera December 8, 2021 18:05:00 - Vimarsana News

CNN CNN Newsroom With Ana Cabrera December 8, 2021 18:05:00

First dose. just considering these latest developments, could that booster timeline change? >> it could, and i think that our federal health officials should be actively evaluating this so that we're not behind when it comes to the recommendations. i will say that the data emerging from south africa, the emerging data from pfizer out this morning are not surprising. actually, this is what we have been anticipating all along, that there's good news and bad news. the bad news being that there's some degree of immune escape, that two doses may not work as well as against previous variants. but i ...